News
Seeing your biggest competitor fail is the next best thing to achieving success yourself. That’s the story of Elevance Health (ELV) and its ...
Elevance Health saw net income fall 2.9% to $2.2 billion during the first quarter, the insurer announced Tuesday.
This compares to the stock's 8% gain over the past four weeks. Elevance Health’s share price benefited from investors seeking stability amid heightened market volatility. A sharp sell-off in ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
ELEVANCE HEALTH ($ELV) is expected to release its quarterly earnings data on Tuesday, April 22nd before market open, per Finnhub. Analysts are expecting revenue of ...
For full-year 2024, Elevance reported $175.2 billion in revenue, an increase of 2.9% over its $170.2 billion haul in 2023.
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
2d
Elevance Health posts strong Q1 with premium, Medicare, and CarelonRx growth, reaffirming 2025 EPS guidance above Wall Street estimates.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback